Shefferman Jesse
SEC CIK 1799167 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | CEO, Pres, Dir | 691.8K | $34.8K | $882.2K | 23 | 2022-01-03 | 2026-06-30 |
Most active insiders at TARA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shefferman Jesse | CEO, Pres, Dir | — | $882.2K |
| 2 | Zummo Jacqueline | Chief R, D Off | — | $125.0K |
| 3 | Nicacio Leonardo Viana | Chief Medical Off | — | — |
| 4 | Fry Hannah | VP, Ctrl | — | — |
| 5 | CONKLING WILLIAM | Chief Commercial Off | — | — |
| 6 | Fabbio Patrick | CFO | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-01 16:10 | 2026-06-29 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | M - OptEx | $1.91 | +215.7K | 937.5K | +30% | +$412.0K |
| D | 2026-07-01 16:10 | 2026-06-29 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | S - Sale+OE | $4.09 | -215.7K | 721.8K | -23% | -$882.2K |
| DM | 2026-07-01 16:10 | 2026-06-30 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -30.0K | 691.8K | -4% | $0 |
| 2026-01-27 | 2026-01-26 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $6.67 | -8,732 | 1.02M | -0.8% | -$58.2K | |
| 2026-01-22 | 2026-01-20 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $5.60 | -16.3K | 1.03M | -2% | -$91.4K | |
| D | 2026-01-21 | 2026-01-16 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +87.0K | 1.05M | +9% | $0 |
| 2025-07-07 | 2025-06-24 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -300.0K | 659.9K | -31% | $0 | |
| M | 2025-06-30 | 2025-06-26+ | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -18.7K | 963.3K | -2% | $0 |
| D | 2025-01-28 | 2025-01-24 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +65.0K | 994.0K | +7% | $0 |
| 2025-01-23 | 2025-01-21 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $4.76 | -15.5K | 913.6K | -2% | -$73.6K | |
| 2025-01-07 | 2025-01-03 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $6.14 | -6,479 | 929.0K | -0.7% | -$39.8K | |
| M | 2024-08-30 | 2024-08-28 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -8,563 | 935.5K | -0.9% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +59.0K | 951.9K | +7% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $1.91 | -7,803 | 944.1K | -0.8% | -$14.9K |
| 2024-01-12 | 2024-01-10 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $2.39 | -5,746 | 892.9K | -0.6% | -$13.7K | |
| 2024-01-05 | 2024-01-03 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $2.17 | -5,840 | 898.6K | -0.6% | -$12.7K | |
| M | 2023-06-27 | 2023-06-23+ | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -9,310 | 911.9K | -1% | $0 |
| D | 2023-01-20 | 2023-01-19 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +51.3K | 918.3K | +6% | $0 |
| 2023-01-11 | 2023-01-10 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $3.00 | -5,855 | 867.0K | -0.7% | -$17.6K | |
| 2023-01-04 | 2023-01-03 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $2.80 | -6,604 | 872.8K | -0.8% | -$18.5K | |
| 2022-08-15 | 2022-08-11 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | P - Purchase | $3.84 | +9,065 | 879.4K | +1% | +$34.8K | |
| 2022-01-12 | 2022-01-10 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $6.27 | -5,080 | 872.4K | -0.6% | -$31.9K | |
| D | 2022-01-05 | 2022-01-03 | TARA | Protara Therapeutics, Inc. | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +42.3K | 877.5K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations